stockrowNovo Integrated Sciences, Inc. (NVOS) vs Syra Health Corp. (SYRA)
- Novo Integrated Sciences, Inc. NVOS 0.00 NaN
- Syra Health Corp. SYRA 0.80 −8.05%
Novo Integrated Sciences, Inc. and Syra Health Corp. are both Medical Care Facilities companies. Syra Health Corp. is the larger, with a market value of $1.1M against $730.0K — 1.5× the size. Novo Integrated Sciences, Inc. has negative trailing earnings, so its P/E is not meaningful; Syra Health Corp. trades at 14.7×. Syra Health Corp. grew revenue faster over the last twelve months: 19.5% against 5.75%. Syra Health Corp. has the higher net margin (7.83% vs −121.6%) and the higher return on invested capital (59.2% vs −42.4%). Across the 15 metrics below, Syra Health Corp. leads on 12 and Novo Integrated Sciences, Inc. on 3.
Valuation
Profitability
| Metric | NVOS | SYRA | Medical Care Facilities median |
|---|---|---|---|
| Gross margin | 43.19% | 42.57% | 30.56% |
| Operating margin | (75.79%) | 6.77% | 6.62% |
| Net margin | (121.61%) | 7.83% | 3.08% |
| Free cash flow margin | (38.54%) | 7.66% | 7.22% |
| Return on equity | (82.67%) | 26.80% | 6.41% |
| Return on assets | (47.76%) | 18.73% | 2.78% |
| Return on invested capital | (42.44%) | 59.24% | 7.44% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack